The Clinical effectiveness and the radiation safety of newly developed Multileaf Collimator

새로 개발된 Multi-leaf Collimator의 임상 유효성 및 방사선 안전성에 관한 연구

  • Yi, B.Y. (Department of Radiation Oncology, Asan Medical Center college of medicine University of Ulsan) ;
  • Kim, J.H. (Department of Radiation Oncology, Asan Medical Center college of medicine University of Ulsan) ;
  • Ahn, S.D. (Department of Radiation Oncology, Asan Medical Center college of medicine University of Ulsan) ;
  • Kim, M.H. (Department of physics, Asan Medical Center college of medicine University of Ulsan) ;
  • Chang, H. (Department of Radiation Oncology, Asan Medical Center college of medicine University of Ulsan)
  • 이병용 (서울중앙병원 방사선 종양학과, 울산대학교 의과대학 치료방사선과학 교실) ;
  • 김종훈 (서울중앙병원 방사선 종양학과, 울산대학교 의과대학 치료방사선과학 교실) ;
  • 안승도 (서울중앙병원 방사선 종양학과, 울산대학교 의과대학 치료방사선과학 교실) ;
  • 김미화 (서울중앙병원 방사선 종양학과, 울산대학교 의과대학 물리학과) ;
  • 장혜숙 (서울중앙병원 방사선 종양학과, 울산대학교 의과대학 치료방사선과학 교실)
  • Published : 1996.05.17

Abstract

We have developed the prototype Multi-leaf Collimator(MLC) for medical linear acclerator. In this study, we have examined the clinical effectiveness of our newly developed MLC by analysing treatment pattern of radiation therapy and studied the radiation safety by measuring the transmitted radiation and the leakage radiation. Over 81% patients can be treated with new MLC(20 pairs of leaves) and 98% with 30 pairs of leafed-MLC, while 95% with commercial MLC. New MLC showed superior properties of radiation leakage and transmission to commercially available MLC.

Keywords